Gritstone bio Inc (GRTS)

[swampboots]

This is an exciting field, but very complicated: hard to find eligible specimens, excruciatingly challenging to prepare, and reliant on many undiscovered
tweeks to the environment increasing the accepting of a positive response.

I could become the leading expert and still not know which Co. has the "goods", and can qualify to ever be profitable. Yet I am very interested as somehow this "thing" (neoantigen) seems to hold a key place in the cancer "game".